MEDICO vs STAR: Stock Comparison

Medico Remedies Limited vs Strides Pharma Science Limited

Live data: 22 July 2026, 2:54 PM IST • Source: NSE and company filings

Strides Pharma Science Limited is the larger company by market capitalisation. Medico Remedies Limited shows faster revenue growth, lower leverage and a higher ROCE, while Strides Pharma Science Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Medico Remedies Limited and Strides Pharma Science Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, MEDICO is more favourable on 5 of 13 scored metrics and STAR on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
STAR is the larger company
₹9,516 Cr vs ₹317 Cr
P/E Ratio
STAR has a lower P/E
17.37x vs 27.22x
P/B Ratio
STAR has a lower P/B
3.11x vs 4.73x
EPS
STAR has higher earnings per share
₹60.31 vs ₹1.58
Dividend Yield
STAR has a higher dividend yield
0.37% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 11.2%
EPS Growth (TTM YoY)
STAR has faster EPS growth
54.4% vs 36.5%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
37.6% vs 11.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICOSTAR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICOSTAR
Live Price₹38.18₹1,040.6
Day Change-1.14%-1.02%
Volume16,5962.25 L
52-Week High₹56.88₹1,231
52-Week Low₹30.22₹768.65
Distance from 52W High-32.88%-15.47%

Valuation

MetricMEDICOSTAR
Market Cap₹317 Cr₹9,516 Cr
P/E Ratio27.22x17.37x
P/B Ratio4.73x3.11x
EPS₹1.58₹60.31
Book Value₹9.15₹337.09
Dividend Yield0%0.37%

Growth

MetricMEDICOSTAR
Revenue Growth (TTM YoY)37.5%11.2%
EPS Growth (TTM YoY)36.5%54.4%
Qtr Sales Growth37.6%11.2%
Qtr Profit Growth35%28.1%

Profitability & Leverage

MetricMEDICOSTAR
ROE19%20.4%
ROCE23.1%18.6%
Net Margin6.36%10.58%
Operating Margin8.25%19%
Debt to Equity0.25x0.57x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricMEDICOSTAR
Promoter Holding61.38%27.91% 0.05 pp
FII Holding0.03% 0.46 pp28.68% 0.84 pp
DII Holding0%14.45% 1.43 pp
Public Holding38.59% 0.46 pp28.95% 0.64 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Medico Remedies Limited and Strides Pharma Science Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.